Average Co-Inventor Count = 7.70
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hanmi Pharm. Co., Ltd. (5 from 146 patents)
2. Hanmi Science Co., Ltd. (3 from 63 patents)
8 patents:
1. 12319695 - Sulfonamide derivative with fused pyrimidine skeleton, having epidermal growth factor receptor mutation inhibitory effect
2. 10464946 - Crystalline forms of thienopyrimidine compound
3. RE47451 - Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases
4. RE46511 - Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
5. 9388165 - Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase
6. 9345719 - Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
7. 9156852 - Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases
8. 8957065 - Fused pyrimidine derivatives for inhibition of tyrosine kinase activity